Copy

December Highlight | Farewell 2018


As 2018 comes to an end, I’ve spent some time reflecting on the work the Institute team has done over the past 12 months.  We have a lot to be thankful for with our successes and new opportunities for growth on the horizon for 2019.  These opportunities are what gives us the strength to find new challenges and think outside the box to continue making the Institute an integral part of the mission and vision of TRIA.
                                                                                     
The team at the Institute wishes you and yours health and happiness in the coming year!

Staff Feature | Lauren Smude, Research Coordinator


This month we would like to highlight our new Research Coordinator, Lauren! In her role, she works closely with our physician investigators handling multiple research studies including 2 of the 3 registry studies here at TRIA, JUPITER and Elbow OCD. She also works closely with patients throughout their time in our research studies from enrollment to the end of the study.

Here are a few questions we asked to get to know her.

Current Studies



IRB Approved Projects:  44
Projects in Development:  23
Data Analysis Phase: 
10

 
Study Background Inclusion/Exclusion Details
Elbow OCD
Study Providers
Bohn
2 year follow up of patient reported outcomes + Age 11 or older
+ OCD lesion of the elbow confirmed by x-ray or MRI
+ Operative or non-operative treatment are both accepted
- Younger than age 11
Follow up questionnaires completed at 3m, 6m, 1y and 2y from time of enrollment
 
No Patient compensation provided
ROCK (OCD)
Study Providers
Nelson
Tompkins
Macalena (UMN)
Long term follow up of patients with OCD lesion of the knee. Consortium or 16 institutions around the US who have created the ROCK group to study the disease + Age 7 or older
+ OCD lesion of the knee confirmed by x-ray or MRI
+ Operative or non-operative treatment pathways are both accepted
- Younger than age 7
Follow up questionnaires completed at 2y, 5y, 10y, 15y, and 25y from time of enrollment
 
No patient compensation provided
 
JUPITER
(Patellar Instability)
Study Providers
Tompkins
2 year follow up of operative or non-operative patella instability. Consortium of 14 sites around the US + Age 10-25
+ Confirmed patellar instability event (dislocation or subluxation)
+ Operative or non-operative treatment pathways are both accepted
- Habitual Patellar dislocation
- Congenital or permanent dislocation
- Multi-ligamentous knee injury
Follow up questionnaires completed at 6m, 1y, 2y from time of enrollment
 
No patient compensation provided
UE Functional Test
(Non-Op)
Study Providers
Kofoed
Responsiveness and clinical utility of an upper extremity functional test following a shoulder instability episode treated non-operatively + Age 16-30
+ Diagnosed shoulder instability dislocation/subluxation or symptoms in the presence of excessive laxity
-Additional injury history to either upper extremity
 
Functional and subjective testing within 21 days of instability episode treated non-operatively and testing again 6 weeks later
 
$25 gift card is provided upon study completion
1st Time Dislocators (OP)
 
Study Providers
Nelson
Braman
Tompkins
Walsh
Determine how quickly patients can safely return to sport following arthroscopic bankart repair for shoulder instability + Age 16-30
+ First time shoulder dislocation or major subluxation event
+ Anterior shoulder dislocation with associated bankart lesion (<25% of glenoid)
+ Participation in the past year in a competitive sport (Varsity, JV, HS Association, Intramural or Recreational)
- Recurrent shoulder dislocations
- HAGL lesion
- Neurologic or vascular injury
- Previous shoulder surgery
- Glenoid fracture
- Concomitant injury that would affect return to sport
Participants will be released to activity by PT as tolerated
Functional and subjective testing for 2 years after surgery (6 visits and 2 phone calls)
 
Required accelerated rehabilitation protocol
 
Non-displaced
Scaphoid Fracture
 
Study Providers
Bohn
Evaluate the safety of allowing scaphoid fx treated surgically to accelerate rehab and allow minimally restricted return to activity immediately after surgery + Age 18-50
+ Isolated closed, non-displaced scaphoid fx
+ ≤ 1mm displacement on CT
+ Surgery within 3 weeks of injury
- Previous wrist injury or surgery
- Hx of rheumatologic or osteoporotic disease
- Steroid use in last 6 months
- Current nicotine use
Accelerated rehabilitation and return to activity or work as tolerated per MD
 
Functional and subjective testing for 6 months after surgery (8 visits)
GelrinC
(Knee cartilage)
 
Study Providers
Nelson
Tompkins
Macalena (UMN)
Evaluating GelrinC hydrogel – applied to cartilage lesions of the femoral condyle treated with microfracture.
 
 
 
+ Age 18-50
+ Single (only 1) cartilage defect of the femoral condyle 1cm2 – 5 cm2
+ BMI< 35
- Meniscus tear
- Grade III or IV symptomatic lesions
- Advanced OA
- Ligamentous injury
- Alignment varus/valgus >5 degrees
- Hyaluronic acid or cortisone injection in last 3 months
Additional study MRIs
 
Patient questionnaires completed at all follow up visits
 
Patient stipend
 
Follow up at 2w, 6w, 3m, 6m, 12m, 18m, 2y, 3y, 4y, 5y

2018 Accomplishments
 

TRIA Orthopedics First in Minnesota to Test Breakthrough GelrinC™ Implant to Regenerate Knee Cartilage

MINNEAPOLIS–(BUSINESS WIRE)–Regentis Biomaterials today announced that Twin Cities-based TRIA Orthopedics is the first in Minnesota to perform a procedure using the GelrinC™ implant to treat damaged articular cartilage causing knee pain. GelrinC (pronounced “gel-rin-cee”) is an investigational device being evaluated as a treatment to help the body regrow cartilage in the knee. TRIA is the only site in Minnesota – and just one of 17 sites nationwide – enrolling patients with knee pain caused by damaged knee cartilage in the SAGE clinical trial. 

Continue reading the full article here.

Publications & Presentations
 

Congratulations to John Shultz and Avais Raja for their publication in JBJS Journal of Orthopaedics for Physician Assistants!




Click here to read the article. 

Opportunity Awaits!
 

Want to become more involved in research? Join us for an upcoming research meeting located in PTEC meeting room 1.
  • Sports sub-specialty group/research committee meets the 2nd Monday of every month at 4p.m.
  • Shoulder sub-specialty group/research committee meets the 2nd Monday of every other month (Jan, Mar, May, July, Sept, Nov) at 5p.m.
  • Hand sub-specialty group/research committee meets the 2nd Monday of every other month (Feb, Apr, Jun, Aug, Oct, Dec) at 5p.m.
Email: institute@tria.com | Vocera: Research Coordinator | Phone: (952) 806-5603
Copyright © 2017 TRIA Orthopaedic Center Research Institute, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
TRIA Orthopaedic Center · 8100 Northland Drive · Minneapolis, MN 55431 · USA

Email Marketing Powered by Mailchimp